Skip to main content
. Author manuscript; available in PMC: 2021 Nov 17.
Published in final edited form as: Virchows Arch. 2019 Sep 2;476(4):535–542. doi: 10.1007/s00428-019-02661-2

Fig 2.

Fig 2

Cancer testis antigen and major histocompatibility complex I expression in high grade urothelial carcinoma. Expression of A. CT10 and B. PRAME in high grade urothelial carcinoma; note the nuclear expression in tumour cells and lack of expression in background stromal/inflammatory cells. C. Retained/normal MHC I expression, compared to D. complete lack of MHC I expression; note the retained expression in background stromal/inflammatory cells. Scale bar = 300 micrometers